GlassScriptPhysician profile
Alok Shah
NPI 1144202474
$13,602.53
in general payments reported to CMS, 2019-2025
9 companies · $2,922 in 2025
The $2,922 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $115 · 2021: $368 · 2022: $2,487 · 2023: $1,707 · 2024: $6,002 · 2025: $2,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,833 · Food and Beverage: $2,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,832.91 |
| Food and Beverage | $2,798.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $11,941.00 | 2021-2025 | Avenir, Arcos, Persona |
| Encore Medical, LP | $1,160.38 | 2022 | |
| Stryker Corporation | $170.07 | 2020-2022 | |
| Depuy Synthes Sales INC. | $142.72 | 2023-2025 | Motoband, Lcp |
| Hitachi Healthcare Americas Corp. | $76.18 | 2020 | |
| Siemens Medical Solutions USA, INC. | $59.70 | 2024 | Magnetom Free.Max |
| Novo Nordisk INC | $26.03 | 2022 | |
| Titan Surgical Group, LLC | $14.17 | 2024 | |
| Medacta USA, INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alok Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.